3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
7
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Blood Specimen Collection
27
Surveys and Questionnaires
24
Magnetic Resonance Spectroscopy
10
Observation
7
Flow Cytometry
7
Specimen Handling
6
Amplified Fragment Length Polymorphism Analysis
6
exemestane
5
Radiotherapy
5
Magnetic Resonance Imaging
5
Immunoenzyme Techniques
5
Biopsy
5
Radiation
4
Neoadjuvant Therapy
4
Mental Status and Dementia Tests
4
Genetic Testing
4
Gene Expression Profiling
4
Electroporation
4
Data Collection
4
Bevacizumab
4
Trastuzumab
3
Tomography, X-Ray Computed
3
Tomography, Optical Coherence
3
Therapeutics
3
Surgical Procedures, Operative
3
Sunitinib
3
Sorafenib
3
Registries
3
Radiosurgery
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Observational
×
duvelisib
×
Clear all
NCT04342117
2021-03-17
REAL
SecuraBio
Terminated
2 enrolled